5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | BUY | BUY | NEUTRAL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 2.66▼ | 2.66▼ | 2.65▼ | 2.50▲ | 2.60▲ |
MA10 | 2.63▼ | 2.60▲ | 2.57▲ | 2.54▲ | 2.73▼ |
MA20 | 2.56▲ | 2.57▲ | 2.57▲ | 2.57▲ | 2.77▼ |
MA50 | 2.57▲ | 2.56▲ | 2.56▲ | 2.77▼ | 2.72▼ |
MA100 | 2.56▲ | 2.61▼ | 2.65▼ | 2.79▼ | 2.74▼ |
MA200 | 2.66▼ | 2.81▼ | 2.84▼ | 2.74▼ | 2.54▲ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.011▲ | 0.011▲ | 0.013▲ | 0.006▲ | -0.040▼ |
RSI | 51.919▲ | 52.097▲ | 51.968▲ | 49.601▼ | 45.223▼ |
STOCH | 75.349 | 81.101▲ | 88.889▲ | 64.283 | 24.174 |
WILL %R | -33.333 | -33.333 | -33.333 | -34.091 | -74.042 |
CCI | 20.080 | 28.976 | 28.998 | 99.183 | -69.323 |
Wednesday, April 30, 2025 06:13 AM
InspireMD seeks to utilize its proprietary MicroNet® technology to make its products the industry standard for carotid stenting by providing outstanding acute results and durable, stroke-free ...
|
Friday, April 25, 2025 06:00 AM
InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard™ Prime carotid stent system for the treatment of carotid artery disease (CAD) and prevention of stroke, today announced that it will release its ...
|
Friday, April 25, 2025 01:30 AM
MIAMI, April 25, 2025 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard™ Prime carotid stent system for the treatment of carotid artery disease (CAD) and prevention of ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
01/05/25 | 2.67 | 2.75 | 2.50 | 2.60 | 59,900 |
30/04/25 | 2.40 | 2.59 | 2.39 | 2.54 | 19,700 |
29/04/25 | 2.43 | 2.43 | 2.43 | 2.43 | 61,872 |
28/04/25 | 2.54 | 2.59 | 2.31 | 2.32 | 47,600 |
25/04/25 | 2.60 | 2.60 | 2.53 | 2.59 | 37,300 |
24/04/25 | 2.60 | 2.60 | 2.58 | 2.60 | 17,400 |
23/04/25 | 2.59 | 2.60 | 2.57 | 2.59 | 22,600 |
22/04/25 | 2.60 | 2.60 | 2.55 | 2.55 | 22,100 |
21/04/25 | 2.60 | 2.60 | 2.54 | 2.60 | 34,400 |
17/04/25 | 2.59 | 2.59 | 2.54 | 2.59 | 61,600 |
|
|
||||
|
|
||||
|
|